Product Description
G-CSF is used in patients who have certain cancers and neutropenia caused by some types of chemotherapy and in patients who have severe chronic neutropenia that is not caused by cancer treatment. It is also used before an autologous stem cell transplant. G-CSF helps the bone marrow make more white blood cells.How Figrastin Injection WorksFigrastin contains Filgrastim, a hematopoietic growth factor, which stimulates the bone marrow to rapidly produce more neutrophils-key white blood cells involved in fighting infections. Its recombinant origin ensures high purity and consistent performance, providing critical support for patients undergoing chemotherapy, bone marrow transplantation, or facing neutrophil deficiencies due to medical conditions.
Who May Benefit from FigrastinPatients with low neutrophil counts caused by chemotherapy, bone marrow transplant, or HIV/AIDS-related conditions are typical candidates for Figrastin. By restoring neutrophil levels, it reduces the risk of infection and complications, helping patients better tolerate intensive treatments or recover from disease-induced immunosuppression.
Proper Storage and HandlingFigrastin should be stored in refrigerators at 2C to 8C, kept away from light, and never frozen to preserve its integrity. The solution is clear, colorless, sterile, odorless, and supplied in a ready-to-use pre-filled syringe or vial, making administration convenient and hygienic in clinical settings.
FAQ's of Figrastin injection:
Q: How should Figrastin injection be administered safely?
A: Figrastin is administered either subcutaneously (under the skin) or intravenously (into a vein) by a healthcare provider. Your doctor will determine the route and dosage appropriate for your medical condition, typically using a single-use vial or pre-filled syringe containing 1 mL per dose.
Q: What conditions are treated with Figrastin injection?
A: Figrastin is primarily used to treat neutropenia (low neutrophil count), especially when caused by chemotherapy, bone marrow transplant, or conditions like HIV/AIDS. It helps reduce infection risk and supports recovery by accelerating neutrophil production.
Q: When should Figrastin injection be given during treatment?
A: The timing of Figrastin injections depends on your medical regimen. Usually, it is given 24 hours after chemotherapy or as directed by your healthcare provider, ensuring optimal enhancement of neutrophil recovery and minimizing treatment delays.
Q: Where should Figrastin injection be stored before use?
A: Store Figrastin in its original carton in a refrigerator at 2C to 8C. Protect it from light and do not freeze. Following these instructions preserves its potency over the 24-month shelf life.
Q: What are the primary benefits of using Figrastin?
A: Figrastin shortens the duration of neutropenia, lowers infection risks, and helps patients continue essential treatments. Its recombinant, high-purity formulation ensures reliability and minimizes adverse reactions associated with impurities.
Q: How is Figrastin manufactured?
A: Figrastin is produced using recombinant DNA technology in E. coli bacteria. This process yields a highly purified, consistent product, carefully formulated without preservatives for patient safety.